Aurora Cannabis Inc. (ACB) |
|
1.32 -0.01 (-0.75%)
|
11-25 13:00 |
|
Open: |
1.33 |
Pre. Close: |
1.33 |
|
High:
|
1.34 |
Low:
|
1.29 |
|
Volume:
|
5,597,658 |
Market Cap:
|
428(M) |
|
|
|
Technical analysis |
as of: 2022-11-25 1:54:52 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.62  One year: 1.89 |
| Support: |
Support1: 1.02 Support2: 0.85 |
| Resistance: |
Resistance1: 1.39 Resistance2: 1.62 |
| Pivot: |
1.37 |
| Moving Average: |
MA(5): 1.32 MA(20): 1.36 
MA(100): 1.38 MA(250): 2.73 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 31.8 %D(3): 32.3 |
| RSI: |
RSI(14): 49.3 |
| 52-week: |
High: 6.73 Low: 0.98 |
| Average Vol(K): |
3-Month: 12,072 (K) 10-Days: 13,407 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ACB ] has closed above bottom band by 36.2%. Bollinger Bands are 8.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.37 - 1.38 |
1.38 - 1.39 |
|
Low:
|
1.28 - 1.29 |
1.29 - 1.29 |
|
Close:
|
1.32 - 1.33 |
1.33 - 1.34 |
|
Company Description |
|
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada. |
Headline News |
Sat, 26 Nov 2022
Probes could be hit as Lokayukta gets ACB workload, but not staff - Deccan Herald
Sat, 26 Nov 2022
Malawi vice president arrested on corruption charges: Watchdog - TRT World
Fri, 25 Nov 2022
Halo Foundation’s ‘Music for a Cause’ benefits from donation from ACB Caribbean Group - Antigua Observer
Fri, 25 Nov 2022
Tristan Vukcevic reportedly offered to ACB teams - Eurohoops
Thu, 24 Nov 2022
ACB investigates SPC over Buluma accusations - Nyasa Times
Sat, 19 Nov 2022
Tenerife routs Valencia for 7-1 ACB start - Eurohoops
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
324 (M) |
| Shares Float |
307 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
19.4 (%) |
|
Shares Short
|
29,930 (K) |
|
Shares Short P.Month
|
33,160 (K) |
Stock Financials |
|
EPS
|
-4.71 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.85 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-110.9 |
|
Return on Assets (ttm)
|
-7.9 |
|
Return on Equity (ttm)
|
-134.3 |
|
Qtrly Rev. Growth
|
-18 |
|
Gross Profit (p.s.)
|
0.06 |
|
Sales Per Share
|
0.64 |
|
EBITDA (p.s.)
|
-0.53 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-118 (M) |
|
Levered Free Cash Flow
|
-112 (M) |
Stock Valuations |
|
PE Ratio
|
-0.29 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.71 |
|
Price to Sales
|
2.03 |
|
Price to Cash Flow
|
-3.62 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-05-10 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
